Publications by authors named "Deborah Lenoci"

Claim this Profile
L
LAT1 expression in head and neck cancer: a prognostic biomarker with potential relevance for BNCT.
Stefano Cavalieri, Imperia Nuzzolese, Deborah Lenoci, Marta Lucchetta, Marica Ficorilli

Front Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The interplay of hypoxia, inflammation, and microbiota as indicators of malignant transformation in oral potentially malignant disorders.
Cristina Gurizzan, Armando G Licata, Luigi Lorini, Cesare Piazza, Davide Mattavelli, Deborah Lenoci

Oral Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal assessment of plasma EBV-DNA in non-endemic EBV-related nasopharyngeal cancer (NPC): the LEA study.
Salvatore Alfieri, Rebecca Romanò, Sara Marceglia, Carolina Sciortino, Walter Ferrari Bravo, Deborah Lenoci

Eur J Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interplay between MRI radiomics and immune gene expression signatures in oral squamous cell carcinoma.
Anna Corti, Deborah Lenoci, Valentina D A Corino, Davide Mattavelli, Marco Ravanelli

Sci Rep· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Claudin-1 in Head and Neck Squamous Cell Carcinoma.
Stefano Cavalieri, Cristiana Bergamini, Deborah Lenoci, Arianna Ottini, Marta Lucchetta

Oncology· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Tumor molecular landscape of Epstein-Barr virus (EBV) related nasopharyngeal carcinoma in EBV-endemic and non-endemic areas: Implications for improving treatment modalities" [Transl. Res. 265 (2024) 1-16].
Deborah Lenoci, Carlo Resteghini, Mara S Serafini, Federico Pistore, Silvana Canevari

Transl Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Ferroptosis-Related Gene Signatures: Prognostic Role in HPV-Positive Oropharyngeal Squamous Cell Carcinoma.
Deborah Lenoci, Mara Serena Serafini, Marta Lucchetta, Stefano Cavalieri, Ruud H Brakenhoff

Cancers (Basel)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral cancer in young adults: incidence, risk factors, prognosis, and molecular biomarkers.
Deborah Lenoci, Elisa Moresco, Stefano Cavalieri, Cristiana Bergamini, Erica Torchia

Front Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor molecular landscape of Epstein-Barr virus (EBV) related nasopharyngeal carcinoma in EBV-endemic and non-endemic areas: Implications for improving treatment modalities.
Deborah Lenoci, Carlo Resteghini, Mara S Serafini, Federico Pistore, Silvana Canevari

Transl Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dietary intervention for tertiary prevention in head and neck squamous cell carcinoma survivors: clinical and translational results of a randomized phase II trial.
Stefano Cavalieri, Eleonora Bruno, Mara Serena Serafini, Deborah Lenoci, Silvana Canevari

Front Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab.
Mara Serena Serafini, Stefano Cavalieri, Lisa Licitra, Federico Pistore, Deborah Lenoci

J Immunother Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MRI-based radiomic prognostic signature for locally advanced oral cavity squamous cell carcinoma: development, testing and comparison with genomic prognostic signatures.
Anna Corti, Loris De Cecco, Stefano Cavalieri, Deborah Lenoci, Federico Pistore

Biomark Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Inflammatory Signature to Predict the Clinical Benefit of First-Line Cetuximab Plus Platinum-Based Chemotherapy in Recurrent/Metastatic Head and Neck Cancer.
Stefano Cavalieri, Mara Serena Serafini, Andrea Carenzo, Silvana Canevari, Deborah Lenoci

Cells· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Copy number alterations in stage I epithelial ovarian cancer highlight three genomic patterns associated with prognosis.
Chiara Pesenti, Luca Beltrame, Angelo Velle, Robert Fruscio, Marta Jaconi, Deborah Lenoci

Eur J Cancer· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
hacksig: a unified and tidy R framework to easily compute gene expression signature scores.
Andrea Carenzo, Federico Pistore, Mara S Serafini, Deborah Lenoci, Armando G Licata

Bioinformatics· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological properties of hypoxia-related gene expression models/signatures on clinical benefit of anti-EGFR treatment in two head and neck cancer window-of-opportunity trials.
Deborah Lenoci, Andrea Carenzo, Stefano Cavalieri, Federico Pistore, Mara Serena Serafini

Oral Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heart Rate in Patients with SARS-CoV-2 Infection: Prevalence of High Values at Discharge and Relationship with Disease Severity.
Alessandro Maloberti, Nicola Ughi, Davide Paolo Bernasconi, Paola Rebora, Iside Cartella, Deborah Lenoci

J Clin Med· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis